In last trading session, Outlook Therapeutics Inc (NASDAQ:OTLK) saw 0.75 million shares changing hands with its beta currently measuring 0.49. Company’s recent per share price level of $1.56 trading at -$0.08 or -4.88% at ring of the bell on the day assigns it a market valuation of $49.95M. That closing price of OTLK’s stock is at a discount of -723.72% from its 52-week high price of $12.85 and is indicating a premium of 44.23% from its 52-week low price of $0.87.
For Outlook Therapeutics Inc (OTLK), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.40. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.52 in the current quarter.
Outlook Therapeutics Inc (NASDAQ:OTLK) trade information
Upright in the red during last session for losing -4.88%, in the last five days OTLK remained trading in the red while hitting it’s week-highest on Friday, 02/14/25 when the stock touched $1.56 price level, adding 21.61% to its value on the day. Outlook Therapeutics Inc’s shares saw a change of -17.46% in year-to-date performance and have moved -15.22% in past 5-day. Outlook Therapeutics Inc (NASDAQ:OTLK) showed a performance of -25.36% in past 30-days.
Outlook Therapeutics Inc (OTLK) estimates and forecasts
5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 702.6k for the same. And 5 analysts are in estimates of company making revenue of 2.26M in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -15.45% during past 5 years.
Outlook Therapeutics Inc (NASDAQ:OTLK)’s Major holders
ROSALIND ADVISORS, INC. is the top institutional holder at OTLK for having 0.45 million shares of worth $3.32 million. And as of 2024-06-30, it was holding 3.1534 of the company’s outstanding shares.
On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 442.51 shares of worth $0.69 million or 1.38% of the total outstanding shares. The later fund manager was in possession of 400.51 shares on Nov 30, 2024 , making its stake of worth around $0.62 million in the company or a holder of 1.25% of company’s stock.
